Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Pediatrics
|
February 1, 1994
Clinical consequences and treatment of primary immunodeficiency syndromes characterized by functional T and B lymphocyte anomalies (combined immune deficiency)
F Berthet, F Le Deist, A M Duliege, et al.
The Pediatric Infectious Disease Journal
|
August 1, 1992
Natural history of human immunodeficiency virus type 1 infection in children: prognostic value of laboratory tests on the bimodal progression of the disease
A M Duliege, A Messiah, S Blanche, et al.
Archives Francaises De Pediatrie
|
November 1, 1990
[Prognostic evaluation of severe head injuries in children]
C Jeannin, E Straub, D Devictor, et al.
The Journal of Infectious Diseases
|
October 21, 1998
Neutralization of syncytium-inducing primary isolates by sera from human immunodeficiency virus (HIV)-uninfected recipients of candidate HIV vaccines
S Zolla-Pazner, S Xu, S Burda, et al.
Journal of Virology
|
October 12, 2000
A human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4-, R5-, and dualtropic clade B and C primary isolates
F Verrier, S Burda, R Belshe, et al.
Pediatrics
|
August 1, 1991
Low-dose zidovudine in children with an human immunodeficiency virus type 1 infection acquired in the perinatal period
S Blanche, A M Duliege, M S Navarette, et al.
Clinical and Diagnostic Laboratory Immunology
|
May 1, 1995
Transport of recombinant human CD4-immunoglobulin G across the human placenta: pharmacokinetics and safety in six mother-infant pairs in AIDS clinical trial group protocol 146
W T Shearer, A M Duliege, M W Kline, et al.
The Journal of Infectious Diseases
|
May 1, 1995
Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trial
J O Kahn, K S Steimer, J Baenziger, et al.
Lancet (London, England)
|
July 10, 1993
Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine
D H Schwartz, G Gorse, M L Clements, et al.
The Journal of Pediatrics
|
October 1, 1992
Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infection
R N Husson, Y Chung, J Mordenti, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Pediatrics
|
February 1, 1994
Clinical consequences and treatment of primary immunodeficiency syndromes characterized by functional T and B lymphocyte anomalies (combined immune deficiency)
F Berthet, F Le Deist, A M Duliege, et al.
The Pediatric Infectious Disease Journal
|
August 1, 1992
Natural history of human immunodeficiency virus type 1 infection in children: prognostic value of laboratory tests on the bimodal progression of the disease
A M Duliege, A Messiah, S Blanche, et al.
Archives Francaises De Pediatrie
|
November 1, 1990
[Prognostic evaluation of severe head injuries in children]
C Jeannin, E Straub, D Devictor, et al.
The Journal of Infectious Diseases
|
October 21, 1998
Neutralization of syncytium-inducing primary isolates by sera from human immunodeficiency virus (HIV)-uninfected recipients of candidate HIV vaccines
S Zolla-Pazner, S Xu, S Burda, et al.
Journal of Virology
|
October 12, 2000
A human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4-, R5-, and dualtropic clade B and C primary isolates
F Verrier, S Burda, R Belshe, et al.
Pediatrics
|
August 1, 1991
Low-dose zidovudine in children with an human immunodeficiency virus type 1 infection acquired in the perinatal period
S Blanche, A M Duliege, M S Navarette, et al.
Clinical and Diagnostic Laboratory Immunology
|
May 1, 1995
Transport of recombinant human CD4-immunoglobulin G across the human placenta: pharmacokinetics and safety in six mother-infant pairs in AIDS clinical trial group protocol 146
W T Shearer, A M Duliege, M W Kline, et al.
The Journal of Infectious Diseases
|
May 1, 1995
Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trial
J O Kahn, K S Steimer, J Baenziger, et al.
Lancet (London, England)
|
July 10, 1993
Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine
D H Schwartz, G Gorse, M L Clements, et al.
The Journal of Pediatrics
|
October 1, 1992
Phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infection
R N Husson, Y Chung, J Mordenti, et al.
Page
of 3